Filter by: patients
What is Daclizumab?

This is an immunosuppresant, used to prevent organ rejection in kidney transplant cases. It has also been tested in clinical trials as a treatment for Multiple Sclerosis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 5 4 Efficacy_major Efficacy_slight Efficacy_cant_tell
Participate in clinical trial 4 2 Efficacy_major Efficacy_cant_tell
Prevent organ rejection 3 0
Other 1 0

See all 8 patients currently taking Daclizumab

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
2
None
4

Commonly reported side effects, conditions, and hospitalizations associated with Daclizumab

Rash or skin problems 1
Body Aches 1

Reported Dosages

  monthly 1 mg monthly 1 other monthly 5 mg monthly 150 mg monthly 5 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Daclizumab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 5   Other: 63%
Did not seem to work 2   Did not seem to work: 25%
Doctor's advice 2   Doctor's advice: 25%
Course of treatment ended 1   Course of treatment ended: 13%

See all 7 patients who’ve stopped taking Daclizumab

Currently Taking Daclizumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Daclizumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Daclizumab

Always
5 83%
Usually
0 0%
Sometimes
0 0%
Never
1 17%

Burden

Difficulty being on treatment

Burden of Daclizumab

Very
0 0%
Somewhat
1 17%
A little
1 17%
Not at all
4 67%

Cost

Paid out of pocket

Cost of Daclizumab

$200+
1 33%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 10, 2012.